Quotient, a U.K. focused on blood transfusion diagnostics, unveiled plans for an initial public offering that would raise as much as $75 million. The move continues a steady trickle of IPO movement among testing companies that began late last fall.
AngioDynamics is gearing up for commercialization in the coming year for its latest chronic dialysis cathether, a product that will help protect and grow an already impressive U.S. market presence.
Vermillion's latest financial report yielded a mixed bag of results: Although the company reported a widening net loss due to increased spending for its research and product development, revenue grew for its software-based ovarian cancer diagnostic.
United Orthopedic, a Taiwanese orthopedic implant and surgical instrument maker, has entered the U.S. market.
Biomet, a maker of medical devices based in Warsaw, IN, has reportedly filed with U.S. regulators for an IPO nominally valued at $100 million.
Medtronic is struggling against Edwards Lifesciences in the companies' U.S. battles over transcatheter heart valve patents. But the Minnesota device giant's fortunes in Europe in the bitter fight have taken a significant turn for the better.
Germany's Biotronik said 6-month results from a broader study of a drug-coated balloon to treat leg blood clots showed a major boost in the standard of care compared to standard balloon angioplasty.
Covidien chief executive José Almeida sold 50,000 shares in his company last Friday, worth $3.6 million at the time he sold them, the Ireland-based medical device maker has disclosed.
Edwards Lifesciences reports initial success with the first three human implants of its Fortis mitral transcatheter heart valve, a necessary milestone if the California company is to succeed in both diversifying and broadening its market-leading presence in the transcatheter valve-replacement space.
Texas devicemaker Kinetic Concepts is touting the results of a new independent study that shows its wound-healing therapy system reduces operating room visits and hospital stays compared to the competition.
Metal fixtures are the norm in surgery--but scientists may have found a safer, more durable way to mend broken bones. A new study shows that silk can be used to secure bone material, providing an alternative to traditional devices.
Navidea Biopharmaceuticals is hopeful the expected European Union approval of its Lymphoseek injectable diagnostic imaging agent later this month and a $30 million loan will help stanch its financial hemorrhaging, which saw losses from operations spike to $38.4 million for the year compared to $28 million for the same period in 2012.
Four patients died and 5 others faced brief scares due to problems involving a backup controller used with Thoratec's HeartMate pumps. The company issued a safety alert to hospitals detailing the issue.
The FDA has accepted Navidea Biopharmaceuticals' latest supplemental new drug application to expand the use of its Lymphoseek injectable diagnostic imaging agent to track more kinds of cancers.
Danish medical device maker Coloplast is said to have paid $16 million to settle lawsuits claiming it injured women with vaginal-mesh inserts. With settlement talk swirling around at least 5 more makers of the plagued devices, that has some watchers saying the time may be ripe for a global settlement.
The FDA slapped GE Healthcare with a Class I recall--its most serious designation--for its infant resuscitation devices after the company found that malfunctions in the product could cause death.
Medtronic has revealed details about the mounting legal troubles it faces concerning its Infuse bone growth spinal implant. About 700 lawsuits involving 1,000 personal injury cases are now pending over the controversial product, according to a recent regulatory filing.
France's Carmat has another major milestone to report regarding its artificial heart. The first patient implanted with the device has died after surviving for 74 days.
Nanowerk reported that UCLA researchers have developed a Google Glass app that could enable instant, wireless diagnostic testing for HIV, types of cancer and other diseases.